Why Mineralys Therapeutics, Inc. (MLYS) stock fell 14.5% on Monday, November 2, 2026

Mineralys Therapeutics, Inc. (MLYS) closed at $15.55, down 14.47% on Monday, November 2, 2026, on volume of 4,575,809 shares (3.6× its 3-month average); market value about $1.40B.

What happened

Nexqual found no SEC filing, earnings release, analyst rating change or insider trade for MLYS on Monday, November 2, 2026 or October 30, 2026. The move may reflect news, sector or market moves, or trading flows that these sources do not capture.

More on MLYS

MLYS stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 2, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 4, 2026 at 10:45 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 4, 2026 at 10:45 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt